Assessment of Micronuclei Frequency and Leukocyte Immune Response Indices in Peptic Ulcer Disease Patients Among Al-Hikmah University Students, Ilorin, Nigeria

Authors

  • FD Olalere Department of Haematology and Blood Transfusion Science, University of Ilorin Teaching Hospital, PMB 1459, Ilorin, Kwara State, Nigeria , Department of Medical Laboratory Sciences, Faculty of Basic Medical Sciences, College of Health Sciences, Al-Hikmah University, Ilorin, Kwara State, Nigeria Author
  • LO Olatunbosun Department of Haematology and Blood Transfusion Science, University of Ilorin Teaching Hospital, PMB 1459, Ilorin, Kwara State, Nigeria , Department of Medical Laboratory Sciences, Faculty of Basic Medical Sciences, College of Health Sciences, Al-Hikmah University, Ilorin, Kwara State, Nigeria Author
  • FE Shehu Department of Medical Laboratory Sciences, Faculty of Basic Medical Sciences, College of Health Sciences, Al-Hikmah University, Ilorin, Kwara State, Nigeria Author
  • OO Afolabi Department of Pathology, Faculty of Basic Medical Sciences, University of Ilorin, Ilorin, Kwara State, Nigeria Author
  • LS Tijani Department of Medical Laboratory Sciences, Nigerian Navy College of Health Sciences, Irra Road, Offa, Kwara State, Nigeria Author

Keywords:

Micronuclei frequency, Peptic ulcer disease, White Blood Cells Indices, Haemoglobin Genotype, ABO Blood Grouping, Differential White Blood Cells Count

Abstract

Background: Peptic ulcer disease (PUD) remains a significant global health concern due to its association with Helicobacter pylori (H. pylori) infection, non-steroidal anti-inflammatory drug (NSAID) use, and potential progression to gastric malignancy. This study aimed to assess the frequency of micronuclei (MN), a biomarker of genomic instability and white blood cell (WBC) functional indices among the students’ population that were screened and diagnosed of Peptic ulcer disease.

Methods: A population of 40 participants were selected through structured questionnaire screening and clinical diagnosis. Whole blood and stool samples were collected for analysis. Haematological parameters were evaluated using an automated haematology analyser; Mindray BC 5000 and manual differential counts on Leishman-stained peripheral blood smears. Micronuclei frequency was assessed in cultured peripheral blood lymphocytes using the cytokinesis-block micronucleus (CBMN) assay. ABO blood grouping and haemoglobin genotyping used cellulose acetate electrophoresis. H. pylori status was determined using a rapid stool antigen test.

Results: There was a statistically significant increase in MN frequency in mononuclear cells with prolonged ulcer duration (p < 0.001), rising from 339.17 ± 42.74 cells/10³ (2–9 months) to 473.33 ± 42.74 cells/10³ (3–4 years). No significant increase was observed in binucleated cells (p > 0.05). No significant differences in MN frequency were observed across ABO blood groups or haemoglobin genotypes (AA, AS, AC). WBC functional indices showed no significant correlation with MN frequency (p > 0.05).

Conclusion: Chronic PUD is associated with cumulative genomic damage, reflected by increased MN frequency over time, independent of inflammatory markers or inherited haematological traits. The study underscores the potential utility of the MN assay as a sensitive, non-invasive biomarker for monitoring long-term genomic instability and cancer risk in PUD patients.

References

1. Neysesyan N, Engelman A, Molitoris J, Hanlon A, Sharma NK, Moeslein FM. Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients treated with selective internal radiation therapy. J Gastrointest Oncol. 2022;7(2):269-77.

2. Mayadas P, Khalifa C, Defour JP, Latinne D, Van Pel MC, De Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2022;10:12-4.

3. Lanas Á, Carrera-Lasfuentes P, Arguedas Y, García S, Bujanda L, Calvet X, et al. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. Clin Gastroenterol Hepatol. 2021;13(5):906-12.e2.

4. Kobayashi AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med. 2022;39(4):345-57.

5. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic ulcer disease: A meta-analysis. Lancet. 2020;359(9300):14-22.

6. Fenech M, Orsière T, Duffaud F, Sari-Minodier I, Pompili J, Bellon L, et al. Acentromeric micronuclei are increased in peripheral blood lymphocytes of untreated cancer patients. Mutat Res. 2021;520(1-2):189-98.

7. Bonassi S, El-Zein R, Fenech M. Epidemiology and declining prevalence of peptic ulcer disease: A systematic analysis. Dig Dis Sci. 2021;66(3):629-38.

8. Maksymchuk D. Duodenal ulcer and its complications: Bleeding, perforation, penetration. Int J Health Sci. 2021;5(3):461-73.

9. Holland AJ, Cleveland DW, Compton DA. Genomic instability and aneuploidy: A hallmark of human disease. Annu Rev Pathol Mech Dis. 2021;16:309-30.

10. Kao CY, et al. Monocyte-driven cytokine responses in gastric inflammation. Cell Immunol. 2020;353:104118.

11. Kirkland J, Lartigau E, M'Kacher R, Légal JD, Bridier A, Guichard M. Biological dosimetry after total body irradiation (TBI) for hematologic malignancy patients. Int J Radiat Oncol Biol Phys. 2021;46(1):123-9.

12. Abu-Eisha O, Sollecito TP, Alawi F, Weinstein GS, Newman JG, De Virgilio A. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 2021;42:539-55.

13. Ambrose V. Micronuclei in oral squamous cell carcinoma: A marker of genotoxic damage. Indian J Dent Res. 2020;11:101-6.

14. Akhmadullina YR, Khomenko PO. The role of micronuclei in chromatin elimination. Biol Bull Rev. 2025;15(3):332-43.

15. Akleev P, Thimmarasa VB, Mehrotra V, Arora P. Micronucleus assay for evaluation of genotoxicity in potentially malignant and malignant disorders. J Indian Acad Oral Med Radiol. 2020;23:97-100.

16. Almadi MA, Lu Y, Alali AA, Barkun AN. Peptic ulcer disease. Lancet. 2024;404(10447):68-81.

17. Alipour, M. (2021). Molecular mechanism of Helicobacter pylori-induced gastric cancer. Journal of gastrointestinal cancer, 52(1), 23-30.

18. Alvarez-Garcia VA, Bijjaragi S, Shah N, Kangane S, Ghule HM, Rani SA. Comparative study of frequency of micronuclei in normal, potentially malignant diseases and oral squamous cell carcinoma. J Nat Sci Biol Med. 2021;7:33-8.

19. Arnold SM, Zhang X, Singh R. Micronucleus frequency as a biomarker in hereditary cancer syndromes. Mutagenesis. 2020;35(5):381-90.

20. Bardelčíková A, Šoltys J, Mojžiš J. Oxidative stress, inflammation and colorectal cancer: An overview. Antioxidants. 2023;12(4):901.

21. Bolognessi M, Giacchino M, Guariso G. Management of Helicobacter pylori infection: Recent insights and clinical implications. J Clin Med. 2021;10(4):795.

22. Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2021;390(10094):613-24.

23. Suerbaum S, Josenhans C, Sterzenbach T. Helicobacter-induced genomic instability: Implications for gastric carcinogenesis. Nat Rev Cancer. 2021;21(3):174-87.

24. Singh NP, Verma R, Sharma A. Micronucleus frequency in populations exposed to occupational genotoxic stressors. Environ Mol Mutagen. 2021;62(5):385-94.

Published

2026-10-20

How to Cite

Assessment of Micronuclei Frequency and Leukocyte Immune Response Indices in Peptic Ulcer Disease Patients Among Al-Hikmah University Students, Ilorin, Nigeria. (2026). African Journal of Allied Health Sciences (AJAHS), 3(1), 61-72. https://ajahs.fuhsi.edu.ng/index.php/home/article/view/21